What Might Aducanumab Teach Us About Clinicians' Judgment About Whether to Recommend Emerging Alzheimer's Interventions?

Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab, according to Adam W. Burroughs, MD and Lewis P. Krain, MD: https://t.co/MA6zV7DBfa

RT @JournalofEthics: Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recomme…

Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab, according to Adam W. Burroughs, MD and Lewis P. Krain, MD: https://t.co/dw2UNKbAM2

Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab, according to Adam W. Burroughs, MD and Lewis P. Krain, MD: https://t.co/vGYTexc7WP